Citation: | ZHA Qian, GAO Xiangdong, CHEN Song. Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2021, 52(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20210312 |
[1] |
. JAMA,2020,323(6):548-560.
|
[2] |
Martinez BA,Petersen DA,Gaeta AL,et al. Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. elegans models of Parkinson''s disease[J]. J Neurosci,2017,37(46):11085-11100.
|
[3] |
Runkel ED,Liu S,Baumeister R,et al. Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response[J]. PLoS Genet,2013,9(3):
|
[4] |
Schmidt E,Seifert M,Baumeister R. Caenorhabditis elegans as a model system for Parkinson''s disease[J]. Neurodegener Dis,2007,4(2/3):199-217.
|
[5] |
Shaye DD,Greenwald I. OrthoList:a compendium of C. elegans genes with human orthologs[J]. PLoS One,2011,6(5):
|
[6] |
Kaletta T,Hengartner MO. Finding function in novel targets:C. elegans as a model organism[J]. Nat Rev Drug Discov,2006,5(5):387-398.
|
[7] |
Culetto E,Sattelle DB. A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes[J]. Hum Mol Genet,2000,9(6):869-877.
|
[8] |
Harrington AJ,Hamamichi S,Caldwell GA,et al. C. elegans as a model organism to investigate molecular pathways involved with Parkinson''s disease[J]. Dev Dyn,2010,239(5):1282-1295.
|
[9] |
Li J,Le WD. Modeling neurodegenerative diseases in Caenorhabditis elegans[J]. Exp Neurol,2013,250:94-103.
|
[10] |
González-Hunt CP,Leung MC,Bodhicharla RK,et al. Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans[J]. PLoS One,2014,9(12):
|
[11] |
Lehtonen ?,Jaronen M,Vehvil?inen P,et al. Inhibition of excessive oxidative protein folding is protective in MPP(+) toxicity-induced Parkinson''s disease models[J]. Antioxid Redox Signal,2016,25(8):485-497.
|
[12] |
Cooper JF,Dues DJ,Spielbauer KK,et al. Delaying aging is neuroprotective in Parkinson''s disease:a genetic analysis in C. elegans models[J]. NPJ Parkinsons Dis,2015,1:15022.
|
[13] |
Chen S,Luo S,Zhang Z,et al. VHL-1 inactivation and mitochondrial antioxidants rescue C. elegans dopaminergic neurodegeneration[J]. Protein Cell,2019,10(8):610-614.
|
[14] |
Stiernagle T. Maintenance of C. elegans[J]. WormBook,2006,11:1-11.
|
[15] |
Brenner S. The genetics of Caenorhabditis elegans[J]. Genetics,1974,77(1):71-94.
|
[16] |
Cao X,Wang X,Chen H,et al. Neurotoxicity of nonylphenol exposure on Caenorhabditis elegans induced by reactive oxidative species and disturbance synthesis of serotonin[J]. Environ Pollut,2019,244:947-957.
|
[17] |
Tsai CW,Tsai RT,Liu SP,et al. Neuroprotective effects of betulin in pharmacological and transgenic Caenorhabditis elegans models of Parkinson''s disease[J]. Cell Transplant,2017,26(12):1903-1918.
|
[1] | ZHAO Yan-rong, DING Li, RAO Ya-kun, TANG Xiao-wen, DING Jun-hong. Stability and degradation products of otilonium bromide in different media[J]. Journal of China Pharmaceutical University, 2010, 41(6): 548-554. |
[2] | Stability of influenza vaccine liposome powder[J]. Journal of China Pharmaceutical University, 2010, 41(4): 360-362. |
[3] | YUAN Xue, ZOU Chang, JIANG Li-ping, ZHANG Yun, CHEN Ya-li. In vitro stability of Endostar[J]. Journal of China Pharmaceutical University, 2009, 40(4): 359-363. |
[4] | Application of Thermogravimetry to the Study of Thermal Decomposition Kinetics of Cefalexin and its Stability[J]. Journal of China Pharmaceutical University, 2000, (2): 16-20. |
[5] | Studies on Stability of Lomefloxacin Hydrochloride Injection[J]. Journal of China Pharmaceutical University, 1996, (6): 23-26. |
[6] | Effect of Naringenin on Photo stability of Nifedipine[J]. Journal of China Pharmaceutical University, 1996, (3): 29-32. |
[7] | HPLC Analysis of Ketoprofen Liniment and Its Stability Study[J]. Journal of China Pharmaceutical University, 1993, (4): 215-218. |
[8] | Study on Stability of Dideoxycytidine[J]. Journal of China Pharmaceutical University, 1990, (6): 342-344. |
[9] | DISCUSSION OF STABILITY OF THE YIN-YANG EQUATION[J]. Journal of China Pharmaceutical University, 1987, (1): 40-44. |
[10] | Li Hanyun, Li Fengwen, Liu Guojie, Chen Shuguang, Cheng Yun. PREDICTION OF SHELF-LIFE OF CONTROLLED- RELEASE OPHTHALMIC FILM OF PILOCARPINE[J]. Journal of China Pharmaceutical University, 1984, (3): 1-5. |